Goodlad, R A <br/><br/>
Inhibiting vascular endothelial growth factor receptor-2 signaling reduces tumor burden in the ApcMin/+ mouse model of early intestinal cancer.  [electronic resource] 

 -  Carcinogenesis  Oct 2006 
 - 2133-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0143-3334 
<br/><br/><label>Standard No.: </label>10.1093/carcin/bgl113  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoma--prevention & control<br/>Animals<br/>Female<br/>Genes, APC--physiology<br/>Intestinal Neoplasms--prevention & control<br/>Intestinal Polyps--drug therapy<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Quinazolines--therapeutic use<br/>RNA, Messenger--analysis<br/>Signal Transduction--drug effects<br/>Splenomegaly--prevention & control<br/>Vascular Endothelial Growth Factor Receptor-2--antagonists & inhibitors